Scispace (Formerly Typeset)
  1. Home
  2. Journals
  3. Scandinavian Cardiovascular Journal
  4. 2016
  1. Home
  2. Journals
  3. Scandinavian Cardiovascular Journal
  4. 2016
Showing papers in "Scandinavian Cardiovascular Journal in 2016"
Journal Article•10.1080/14017431.2016.1185532•
Characteristics and survival of adult Swedish PAH and CTEPH patients 2000-2014.

[...]

Göran Rådegran1, Barbro Kjellström2, Björn Ekmehag3, Flemming Larsen4, Bengt Rundqvist5, Sofia Berg Blomquist6, Carola Gustafsson5, Roger Hesselstrand1, Monica Karlsson7, Björn Kornhall1, Magnus Nisell4, Liselotte Persson1, Henrik Ryftenius4, Maria Selin8, Bengt Ullman2, Kent Wall9, Gerhard Wikström6, Maria Willehadson6, Kjell Jansson7, Spahr •
Lund University1, Karolinska Institutet2, Uppsala University Hospital3, Karolinska University Hospital4, Sahlgrenska University Hospital5, Uppsala University6, Linköping University7, Umeå University8, Örebro University9
14 Jun 2016-Scandinavian Cardiovascular Journal
TL;DR: The majority of the PAH and CTEPH patients were diagnosed at age >65 years, in functional class III–IV, and exhibiting several comorbidities, and PAH survival in SPAHR was similar to other registers.
Abstract: Objectives: The Swedish Pulmonary Arterial Hypertension Register (SPAHR) is an open continuous register, including pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hyperte ...

125 citations

Journal Article•10.3109/14017431.2016.1154598•
Safe orthotopic transplantation of hearts harvested 24 hours after brain death and preserved for 24 hours.

[...]

Stig Steen1, Audrius Paskevicius1, Qiuming Liao1, Trygve Sjöberg1•
Lund University1
04 Apr 2016-Scandinavian Cardiovascular Journal
TL;DR: Orthotopic transplantation of porcine donor hearts harvested 24’hours after brain death and preserved for 24 hours can be done safely, and the adrenaline test showed a dose dependent response.
Abstract: Objectives. The aim of this study was to demonstrate safe orthotopic transplantation of porcine donor hearts harvested 24 hours after brain death and preserved for 24 hours before transplantation. Design. Circulatory normalization of brain dead (decapitated) pigs was obtained using a new pharmacological regimen (n = 10). The donor hearts were perfused at 8 °C in cycles of 15 min perfusion followed by 60 min without perfusion. The perfusate consisted of an albumin-containing hyperoncotic cardioplegic nutrition solution with hormones and erythrocytes. Orthotopic transplantation was done in 10 recipient pigs after 24 hours’ preservation. Transplanted pigs were monitored for 24 hours, then an adrenaline stress test was done. Results. All transplanted pigs were stable throughout the 24-hour observation period with mean aortic pressure around 80 mmHg and normal urine production. Mean right and left atrial pressures were in the range of 3–6 and 5–10 mmHg, respectively. Blood gases at 24 hours did not dif...

118 citations

Journal Article•10.1080/14017431.2016.1233351•
Review of remote ischemic preconditioning: from laboratory studies to clinical trials

[...]

Vesa Anttila1, Henri Haapanen2, Fredrik Yannopoulos2, Johanna Herajärvi2, Tuomas Anttila2, Tatu Juvonen •
Turku University Hospital1, University of Oulu2
20 Sep 2016-Scandinavian Cardiovascular Journal
TL;DR: RIPC has a great prospect for ischemic protection of the heart and other organs and should be explored, not only in cardiac protection, but also in patients with threatening ischemia of the brain, organ transplantation of theheart, liver and kidney and extensive cardiovascular surgery.
Abstract: In remote ischemic preconditioning (RIPC) short periods of non-lethal ischemia followed by reperfusion of tissue or organ prepare remote tissue or organ to resist a subsequent more severe ischemia-reperfusion injury. The signaling mechanism of RIPC can be humoral communication, neuronal stimulation, systemic modification of circulating immune cells, and activation of hypoxia inducible genes. Despite promising evidence from experimental studies, the clinical effects of RIPC have been controversial. Heterogeneity of inclusion and exclusion criteria and confounding factors such as comedication, anesthesia, comorbidities, and other risk factors may have influenced the efficacy of RIPC. Although the cardioprotective pathways of RIPC are more widely studied, there is also evidence of benefits in CNS, kidney and liver protection. Future research should explore the potential of RIPC, not only in cardiac protection, but also in patients with threatening ischemia of the brain, organ transplantation of the heart, liver and kidney and extensive cardiovascular surgery. RIPC is generally well-tolerated, safe, effective, and easily feasible. It has a great prospect for ischemic protection of the heart and other organs.

46 citations

Journal Article•10.3109/14017431.2015.1119304•
Treatment pattern of contemporary dual antiplatelet therapies after acute coronary syndrome: a Swedish nationwide population-based cohort study.

[...]

Oskar Angerås1, Pål Hasvold2, Marcus Thuresson, Anna Deleskog2, Oscar ÖBraun3 •
Sahlgrenska University Hospital1, AstraZeneca2, Lund University3
03 Mar 2016-Scandinavian Cardiovascular Journal
TL;DR: Among DAPT-treated patients, ticagrelor has emerged as the preferred P2Y12 antagonist in patients undergoing angiography, whereas clopidogrel tended to be prescribed to patients treated non-invasively.
Abstract: Objectives New dual antiplatelet therapies (DAPTs) have been introduced in clinical practice for patients with acute coronary syndrome (ACS). This nationwide study investigated DAPT patterns over time and patient characteristics associated with the various treatments in a population with ACS. Design This observational cohort study linked morbidity, mortality and medication data from Swedish national registries. Results Overall, 91% (104 012 patients) of all patients admitted to the hospital with an ACS (2009–2013) were alive after discharge and included in this study. Compared with 2009, in 2013 patients investigated with angiography increased by 10%, patients revascularized with percutaneous coronary intervention (PCI) increased by 11% and patients prescribed DAPT increased by 8%. Mean DAPT duration increased from 225 to 298 days in patients investigated with angiography, and from 155 to 208 days in patients who were not investigated with angiography. Furthermore, in patients undergoing angiograp...

40 citations

Journal Article•10.1080/14017431.2016.1235284•
The Nordic Consortium for Acute type A Aortic Dissection (NORCAAD) : objectives and design *

[...]

Arnar Geirsson1, Anders Ahlsson2, Anders Franco-Cereceda3, Simon Fuglsang4, Jarmo Gunn5, Emma Hansson6, Vibeke E. Hjortdal4, Kati Järvelä, Anders Jeppsson6, Ari Mennander, Shahab Nozohoor, Christian Olsson3, Anders Wickbom3, Igor Zindovic, Tomas Gudbjartsson1 •
University of Iceland1, Örebro University2, Karolinska University Hospital3, Aarhus University Hospital4, Turku University Hospital5, Sahlgrenska University Hospital6
26 Sep 2016-Scandinavian Cardiovascular Journal
TL;DR: The Nordic Consortium for Acute Type A Aortic Dissection (NORCAAD) is a collaborative effort of Nordic cardiac surgery centers to study acute type A aortic dissection (ATAAD) and provides a foundation for close collaboration between cardiac surgery center in the Nordic countries.
Abstract: Objectives. The Nordic Consortium for Acute Type A Aortic Dissection (NORCAAD) is a collaborative effort of Nordic cardiac surgery centers to study acute type A aortic dissection (ATAAD). Here, we outline the overall objectives and the design of NORCAAD. Design. NORCAAD currently consists of eight centers in Denmark, Finland, Iceland and Sweden. Data was collected for patients undergoing surgery for ATAAD from 2005 to 2014. A total of 194 variables were retrospectively collected including demographics, past medical history, preoperative medications, symptoms at presentation, operative variables, complications, bleeding and blood transfusions, need for late reoperations, 30-day mortality and long-term survival. Results. Information was gathered in the database for 1159 patients, of which 67.6% were male. The mean age was 61.5 ± 12.1 years. The mean follow-up was 3.1 ± 2.9 years with a total of 3535 patient years. Conclusions. NORCAAD provides a foundation for close collaboration between cardiac sur...

37 citations

Journal Article•10.3109/14017431.2015.1103893•
Effects of vitamin D supplementation as an adjuvant therapy in coronary artery disease patients.

[...]

Zhao-ke Wu1, Ting Wang, Shen-shen Zhu1, Ling Li1•
Zhengzhou University1
01 Jan 2016-Scandinavian Cardiovascular Journal
TL;DR: Vitamin D supplementation has beneficial effects on coronary artery disease; it can be an adjuvant therapy for patients with coronary artery patients residing in Beijing.
Abstract: Objectives: Low vitamin D status has been shown to be associated with coronary artery disease. We planned to research the effects of vitamin D3 supplementation on the severity of coronary artery disease. Design: We investigated the effect of 0.5 μg vitamin D3 per day in a randomized, placebo-controlled, double-blind study in 90 stable coronary artery disease patients residing in Beijing. Coronary angiography was performed before and after 6 months of treatment that took place between January and June. 25-Hydroxyvitamin D was measured by chemiluminescence assay. Coronary artery disease severity was assessed by using the SYNTAX scores. Results: In vitamin D supplementation group, there was a significant increase in mean 25-hydroxyvitamin D levels from baseline (19.9 ± 9.8 ng/ml) to 6 months (35.8 ± 12.1 ng/ml; p < 0.001). At 6 months, the primary end point, a difference in the fall of SYNTAX score between the groups was −2.5 (95% CI −5.1 to −0.5; p < 0.001) under intention to treat analysis. Compare...

36 citations

Journal Article•10.1080/14017431.2016.1239837•
The Tromsø study 1974-2016: 40 years of cardiovascular research.

[...]

Inger Njølstad1, Ellisiv B. Mathiesen2, Henrik Schirmer2, Dag S. Thelle3•
University of Tromsø1, University Hospital of North Norway2, University of Gothenburg3
24 Oct 2016-Scandinavian Cardiovascular Journal
TL;DR: Total cholesterol, blood pressure and smoking declined after 1974, corresponding to the subsequent decline in coronary heart disease mortality, and reduced incidence accounted for 40% of the mortality decline, while a substantial reduction in case fatality explained the remaining 60%.
Abstract: The rapid increase of coronary heart disease mortality in Northern Norway during 1951-1970 was why the newly established University of Tromso decided to start a study to identify major operating cardiovascular risk factors. The first Tromso survey in 1974 suggested that the relatively high cardiovascular mortality was associated with elevated cholesterol levels and high prevalence of smoking, while high-density-lipoprotein-cholesterol (HDL-C) was identified as a preventive factor. After 1974, six more surveys including both genders (aged 20-89 years) were undertaken. The second survey (1979) revealed the cholesterol increasing effect of coffee. Echocardiographic examinations, ECG, and ultrasound of carotid arteries were introduced in later surveys, and intervention studies were established. Repeated carotid measurements showed that inflammation was involved in novel plaque formation, while HDL-C was protective. Moderate physical activity protected against atrial fibrillation but hard exercise increased the risk. Obesity, hypertension and smoking increased the risk of aortic stenosis, and diastolic dysfunction predicted development of atrial fibrillation. Dilated left atria predicted stroke, especially for individuals without known atrial fibrillation. Total cholesterol, blood pressure and smoking declined after 1974, corresponding to the subsequent decline in coronary heart disease mortality. Reduced incidence accounted for 40% of the mortality decline, while a substantial reduction in case fatality explained the remaining 60%.

34 citations

Journal Article•10.3109/14017431.2016.1173226•
Effect of cholecalciferol supplementation on arterial stiffness: a systematic review and meta-analysis.

[...]

Sikarin Upala1, Anawin Sanguankeo1, Soontharee Congrete, Veeravich Jaruvongvanich2•
Mahidol University1, University of Hawaii2
18 May 2016-Scandinavian Cardiovascular Journal
TL;DR: A systematic review and meta-analysis of randomized controlled trials (RCTs) investigating the impact of vitamin D supplementation on arterial stiffness found there was no improvement of markers of arterIAL stiffness after vitamin D supplements.
Abstract: Background: Vitamin D deficiency increases risk of cardiovascular diseases, arterial stiffness, and endothelial dysfunction. We conducted a systematic review and meta-analysis of randomized controlled trials (RCTs) investigating the impact of vitamin D supplementation on arterial stiffness.Methods: A comprehensive search of the databases of the Cochrane Central Register of Controlled Trials, MEDLINE, and EMBASE was performed from inception through November 2015. The inclusion criterion was RCTs that assessed the impact of cholecalciferol supplementation in adults on the surrogate markers of arterial stiffness (aortic pulse wave velocity (PWV) and augmentation index (AIx)). Outcome was the pooled mean difference (MD) of PWV and AIx between the vitamin D supplementation (intervention) group and placebo.Results: The initial search yielded 1164 articles. Twenty-eight articles underwent full-length review and data were extracted from seven RCTs involving totally 547 participants. Dose of cholecalcifero...

29 citations

Journal Article•10.3109/14017431.2015.1111408•
The role of medical and psychosocial factors for unfavourable coronary risk factor control

[...]

John Munkhaugen1, Elise Sverre1, Kari Peersen, Erik Gjertsen1, Lars Gullestad2, Torbjørn Moum3, Jan Erik Otterstad, Joep Perk4, Einar Husebye1, Toril Dammen3 •
Drammen Hospital1, Oslo University Hospital2, University of Oslo3, Linnaeus University4
01 Jan 2016-Scandinavian Cardiovascular Journal
TL;DR: If the study variables contribute to CHD risk factors and prognosis, the present project may be important for the development of prevention programs by tailoring these to the patients perceived needs and behaviour profiles.
Abstract: Objectives. This project aims to identify socio-demographic, medical and psychosocial factors (study factors) associated with coronary risk control and prognosis, and to test their impact in a repr ...

26 citations

Journal Article•10.1080/14017431.2016.1210212•
Comorbidity burden is not associated with higher mortality after out-of-hospital cardiac arrest*

[...]

Matilde Winther-Jensen1, Jesper Kjaergaard1, Niklas Nielsen, Michael A. Kuiper, Hans Friberg2, Helle Søholm1, Jakob Hartvig Thomsen1, Martin Frydland1, Christian Hassager1 •
Copenhagen University Hospital1, Lund University2
28 Jul 2016-Scandinavian Cardiovascular Journal
TL;DR: Comorbidity burden was associated with higher mortality following OHCA, but when adjusting for confounders, the influence was no longer significant and the association between mCI and mortality was not modified by TTM.
Abstract: Objectives. We investigated whether comorbidity burden of comatose survivors of out-of-hospital cardiac arrest (OHCA) affects outcome and if comorbidity modifies the effect of target temperature management (TTM) on final outcome. Design. The TTM trial randomized 939 patients to 24 h of TTM at either 33 or 36 °C with no difference regarding mortality and neurological outcome. This post-hoc study of the TTM-trial formed a modified comorbidity index (mCI), based on available comorbidities from the Charlson comorbidity index (CCI). Results. Bystander cardiopulmonary resuscitation (CPR) decreased with higher comorbidity group, p = 0.01. Comorbidity groups were univariately associated with higher mortality compared to mCI0 (HRmCI1: 1.55, CI: 1.25–1.93, p < 0.001, HRmCI2: 2.01, CI: 1.55–2.62, p < 0.001, HRmCI ≥ 3: 2.16, CI: 1.57–2.97, p < 0.001). When adjusting for confounders there was a consistent, nonsignificant association between level of comorbidity and mortality (HRmC11: 1.17, CI: 0.92–1.48, p = 0...

26 citations

Journal Article•10.3109/14017431.2015.1136079•
Cardiomyocyte Ca2+ dynamics: clinical perspectives.

[...]

Jan Magnus Aronsen1, William E. Louch2, Ivar Sjaastad2•
Bjørknes College1, Oslo University Hospital2
07 Feb 2016-Scandinavian Cardiovascular Journal
TL;DR: The role of local Ca2+ homeostasis in healthy cardiac muscle cells is summarized, and how mismanaged Ca2+.
Abstract: In the heart, Ca(2+) signals regulate a variety of biological functions ranging from contractility to gene expression, cellular hypertrophy and death. In this review, we summarize the role of local Ca(2+) homeostasis in these processes in healthy cardiac muscle cells, and highlight how mismanaged Ca(2+) handling contributes to the pathophysiology of conditions such as cardiac arrhythmia, ischemic heart disease, cardiac hypertrophy and heart failure. Aiming to provide an introduction to the field with a clinical perspective, we also indicate how current and future therapies may modulate cardiomyocytes Ca(2+) handling for the treatment of patients.
Journal Article•10.3109/14017431.2015.1099720•
Protamine reduces whole blood platelet aggregation after cardiopulmonary bypass

[...]

Anki Olsson1, Joakim Alfredsson, Erik Håkansson, Rolf Svedjeholm2, Johan Berglund1, Sören Berg •
Blekinge Institute of Technology1, Linköping University2
01 Jan 2016-Scandinavian Cardiovascular Journal
TL;DR: Platelet aggregation was reduced by approximately 50% after in vivo protamine administration and protamine added in vitro also reduces platelet aggregation, by itself or in combination with heparin.
Abstract: Objectives: Platelet dysfunction is an important cause of postoperative bleeding after cardiac surgery. Protamine is routinely used for reversal of heparin after cardiopulmonary bypass (CBP), but m ...
Journal Article•10.3109/14017431.2015.1098725•
Vitamin D levels predict hospitalization and mortality in patients with heart failure.

[...]

Erdal Belen, Aylin Sungur, Mustafa Azmi Sungur
01 Jan 2016-Scandinavian Cardiovascular Journal
TL;DR: Vitamin D deficiency is highly prevalent in patients with HF, and low vitamin D levels are closely associated with increased hospitalisation and mortality.
Abstract: Objectives: Low levels of vitamin D are closely associated with cardiovascular diseases. Heart failure (HF) is a major health problem globally, occurring with increasing frequency and characterised by poor prognosis despite therapy. We aimed to investigate the effect of vitamin D levels on hospitalisation and mortality in patients with HF. Design: Patients with ejection fraction 50 nmol/L). Median follow-up time was 12 months. Hospitalisation rates and overall survival were compared between groups. Independent predictors of hospitalisation and mortality were defined. Results: With a median follow-up period of 12 months, hospitalisation and overall death occured more frequently in Group 1 than in Group 2 (23.4% vs 7.3% and 16.1% vs 1.2%, respectively; p < 0.005 for both)...
Journal Article•10.3109/14017431.2015.1119303•
Increased red cell distribution width predicts occlusion of the infarct-related artery in STEMI

[...]

Mehmet Kadri Akboga, Çağrı Yayla, Samet Yilmaz, Fatih Sen, Kevser Gülcihan Balci, Firat Ozcan, Dursun Aras 
01 Jan 2016-Scandinavian Cardiovascular Journal
TL;DR: It is suggested that RDW value and WBC count on admission were independent predictors of IRA patency in patients with STEMI, and can be used in daily practice as a novel predictor for IRAPatency.
Abstract: Objective Infarct-related artery (IRA) patency yields a better outcome in patients with ST-segment elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PCI). Red cell distribution width (RDW) emerges as a marker of adverse cardiovascular events and mortality in STEMI. Therefore, we aimed to assess the relationship between IRA patency and RDW value on admission in patients with STEMI undergoing primary PCI. Methods A total of 564 patients with STEMI undergoing primary PCI were recruited in this study. According to thrombolysis in myocardial infarction (TIMI) flow grade in the IRA before PCI, the study population was divided into two groups as TIMI 0 or 1 group (occluded IRA, n = 398) and TIMI 2 or 3 group (patent IRA, n = 166). Results RDW was significantly higher in the occluded IRA group (15.1 ± 1.7 versus 13.4 ± 1.3, p < 0.001) as compared to the patent IRA group. White blood cell (WBC) count, platelet count, creatine kinase-myocardial band (CK-MB) and t...
Journal Article•10.1080/14017431.2016.1240829•
The International Registry of Acute Aortic Dissections (IRAD) – experiences from the first 20 years

[...]

Truls Myrmel1, Magnus Larsen2, Kristian Bartnes1•
University of Tromsø1, University Hospital of North Norway2
02 Nov 2016-Scandinavian Cardiovascular Journal
TL;DR: The International Registry of Acute Aortic Dissections (IRAD) as discussed by the authors is an international collaboration on various aspects of acute aortic syndromes, which has been running since 1998.
Abstract: An international collaboration on various aspects of acute aortic syndromes, IRAD or The International Registry of Acute Aortic Dissections, is celebrating its 20th anniversary this year (2016). In this paper, we present important lessons learned during these first 20 years.
Journal Article•10.1080/14017431.2016.1210213•
Mesenchymal stromal cell therapy in ischemic heart disease

[...]

Jens Kastrup, Naja Dam Mygind1, Abbas Ali Qayyum1, Anders Bruun Mathiasen1, Mandana Haack-Sørensen, Annette Ekblond •
University of Copenhagen1
22 Sep 2016-Scandinavian Cardiovascular Journal
TL;DR: This review will focus on treatment with the mesenchymal stromal cell from bone marrow and adipose tissue in animal and patients with acute and chronic IHD (CIHD).
Abstract: Although, treatment of ischemic heart disease (IHD) has improved considerably within the last decades, it is still the main cause of death worldwide. Despite maximum treatment, many IHD patients suffer from refractory angina and heart failure, which severely limits their daily lives. Moreover, IHD is very costly for the health care system. Therefore, new treatment options and strategies are being researched intensely. Stem cell therapy to improve myocardial perfusion and stimulate growth of new cardiomyocytes could be a new way to go. Nevertheless, the results from clinical studies have varied considerably, probably due to the use of many different cell lines obtained from different tissues and the different patient populations. The present review will focus on treatment with the mesenchymal stromal cell from bone marrow and adipose tissue in animal and patients with acute and chronic IHD (CIHD).
Journal Article•10.3109/14017431.2016.1156736•
Association of thiol disulfide homeostasis with slow coronary flow.

[...]

Harun Kundi, Murat Gök, Mustafa Çetin, Emrullah Kiziltunc, Canan Topcuoglu, Salim Neselioglu1, Ozcan Erel1, Feridun Vasfi Ulusoy •
Yıldırım Beyazıt University1
11 Mar 2016-Scandinavian Cardiovascular Journal
TL;DR: The study showed that thiol disulfide homeostasis was significantly and independently related to the presence of slow coronary flow, and indicated that hsCRP, and thioldisulfide ratio were independently associated withSlow coronary flow.
Abstract: Objective The aim of this study was to investigate the role of thiol disulfide homeostasis in the presence of slow coronary flow. Material and methods In this cross-sectional study, a total of 110 patients who admitted to our hospital between March 2014 and December 2015 were included in the study. There were 65 patients in the slow coronary flow, and 45 patients in the normal flow groups. Results We found significant differences between slow coronary flow and the normal flow groups for thiol disulfide homeostasis, and the results of our study indicated that hsCRP, and thiol disulfide ratio were independently associated with slow coronary flow. Conclusion Our study showed that thiol disulfide homeostasis was significantly and independently related to the presence of slow coronary flow.
Journal Article•10.1080/14017431.2016.1175657•
Echocardiographic measures of atrial function may predict atrial fibrillation in stroke patients.

[...]

David Waldenhjort1, Piotr Sobocinski Doliwa1, Mahbubul Alam1, Viveka Frykman-Kull1, Johan Engdahl, Mårten Rosenqvist1, Hans Persson1 •
Karolinska Institutet1
18 May 2016-Scandinavian Cardiovascular Journal
TL;DR: LAVI and measures of atrial contraction as measured by TDI predict unknown AF in patients after an stroke/TIA and may be used to detect silent AF.
Abstract: Objective: In patients with a prior stroke or transient ischemic attack (TIA) and atrial fibrillation anticoagulant treatment is indicated. This study’s purpose was to investigate if echocardiography can predict unknown AF in patients after stroke.Design: Prospectively, 174 stroke/TIA patients without diagnosed AF underwent echocardiographic evaluation including tissue Doppler imaging (TDI) focusing on functional parameters of the left atrium and left ventricular diastolic function. AF screening was performed during 30 d.Results: Fifteen patients (8.6%) were diagnosed with AF. Echocardiography in the AF group compared to those without AF, showed larger left atrial volume index (LAVI), (37.2 ± 6.7 vs. 31.6 ± 8.6 ml/m2, p = 0.018), lower A’ velocities in ventricular (5.9 ± 2.2 vs. 7.2 ± 1.6, p = 0.010) and atrial (4.8 ± 1.4 vs. 5.9 ± 1.4, p = 0.013) septa, higher LAVI/A’ in ventricular septum (6.7 (5.0–8.7) vs. 4.2 (3.2–5.5), p = 0.001) and atrial septum (8.5 (5.9–11.0) vs. 5.1 (4.1–6.8), p = 0.003)...
Journal Article•10.3109/14017431.2016.1151928•
Increased hsCRP is associated with higher risk of aortic valve replacement in patients with aortic stenosis.

[...]

Adam Blyme1, Camilla Asferg1, Olav W. Nielsen1, Kurt Boman2, Christa Gohlke-Bärwolf, Kristian Wachtell3, Michael H. Olsen4 •
University of Copenhagen1, Umeå University2, Oslo University Hospital3, North-West University4
08 Mar 2016-Scandinavian Cardiovascular Journal
TL;DR: High hs CRP1 or an increase in hsCRP during the first year of follow-up predicted later AVR independently of AVA, age, gender and other risk factors, although no significant improvement in C-statistics was observed.
Abstract: Objective To investigate relations between inflammation and aortic valve stenosis (AS) by measuring high-sensitivity C-reactive protein, at baseline (hsCRP0) and after 1 year (hsCRP1) and exploring associations with aortic valve replacement (AVR). Design We examined 1423 patients from the Simvastatin and Ezetimibe in Aortic Stenosis study. Results During first year of treatment, hsCRP was reduced both in patients later receiving AVR (2.3 [0.9-4.9] to 1.8 [0.8-5.4] mg/l, p < 0.001) and not receiving AVR (1.90 [0.90-4.10] to 1.3 [0.6-2.9] mg/l, p < 0.001). In Cox-regression analyses, hsCRP1 predicted later AVR (HR = 1.17, p < 0.001) independently of hsCRP0 (HR = 0.96, p = 0.33), aortic valve area (AVA) and other risk factors. A higher rate of AVR was observed in the group with high hsCRP0 and an increase during the first year (AVRhighCRP0CRP1inc = 47.3% versus AVRhighCRP0CRP1dec = 27.5%, p < 0.01). The prognostic benefit of a 1-year reduction in hsCRP was larger in patients with high versus low hsCRP0 eliminating the difference in incidence of AVR between high versus low hsCRP0 (AVRhighCRP0CRP1dec = 27.5% versus AVRlowCRP0CRP1dec = 25.8%, p = 0.66) in patients with reduced hsCRP during the first year. Conclusions High hsCRP1 or an increase in hsCRP during the first year of follow-up predicted later AVR independently of AVA, age, gender and other risk factors, although no significant improvement in C-statistics was observed.
Journal Article•10.1080/14017431.2016.1215520•
12-Lead electrocardiogram as a predictor of sudden cardiac death: from epidemiology to clinical practice.

[...]

Antti Eranti, Aapo L. Aro1, Tuomas Kenttä2, Arttu Holkeri1, Jani T. Tikkanen2, M. Juhani Junttila2, Heikki V. Huikuri2 •
Helsinki University Central Hospital1, Oulu University Hospital2
10 Aug 2016-Scandinavian Cardiovascular Journal
TL;DR: Role of the standard electrocardiogram (ECG) in SCD risk stratification has been under active research during the last decade and multiple abnormalities of depolarization and repolarization on the ECG associated with an increased risk of SCD have been identified.
Abstract: Sudden cardiac death (SCD) causes a high burden of premature deaths in the population affecting subjects of all ages. The identification of subjects at high risk for SCD is of great importance as the prevention of many of these events would be possible with the treatment of underlying cardiac diseases and the use of implantable cardioverter-defibrillators (ICD). However, the current selection of patients for ICD therapy is based solely on left ventricular ejection fraction, and thus a substantial portion of patients at high risk does not qualify for the therapy. Role of the standard electrocardiogram (ECG) in SCD risk stratification has been under active research during the last decade and multiple abnormalities of depolarization and repolarization on the ECG associated with an increased risk of SCD have been identified. In this review, we describe the basic pathophysiological principles behind these changes. We also review the current knowledge of the prognostic significance of ECG predictors of SCD in the general population, and in patients with coronary heart disease (CHD), heart failure, cardiomyopathies, and in inheritable arrhythmia syndromes. Also, insights into the novel digital ECG signal processing techniques are provided.
Journal Article•10.1080/14017431.2016.1177198•
4-Year outcome of bioactive stents versus everolimus-eluting stents in acute coronary syndrome.

[...]

Pasi P. Karjalainen, Matti Niemelä1, Mikko Pietilä2, Jussi Sia, Adam de Belder3, Fernando Rivero-Crespo, Bernard De Bruyne, Wail Nammas •
University of Oulu1, Turku University Hospital2, University of Sussex3
18 May 2016-Scandinavian Cardiovascular Journal
TL;DR: In patients presenting with ACS, BAS was associated with a clinical outcome non-inferior to EES at 4-year follow-up, and independent predictors of MACE were calcified lesions, the number of vessels treated, and reference vessel diameter.
Abstract: Objectives: The BASE-ACS trial demonstrated non-inferiority of titanium-nitride-oxide-coated bioactive stents (BAS), versus everolimus-eluting stents (EES), for major adverse cardiac events (MACE) at 1- and 2-year follow-up, in patients with acute coronary syndrome (ACS). We presented the 4-year outcome of the BASE-ACS trial.Design: We randomized 827 patients with ACS to receive either BAS (417) or EES (410). MACE was a composite of cardiac death, non-fatal myocardial infarction (MI) or ischemia-driven target lesion revascularization (TLR) at 12-month follow-up. Analyses were performed by intention to treat. Follow-up was planned at 12 months, and yearly thereafter for 5 years.Results: Four-year clinical follow-up was completed in 753 (91.1%) patients. At 4 years, BAS were non-inferior to EES for MACE (14.7% versus 17.8%, respectively; p = 0.24 for superiority; p = 0.001 for non-inferiority). Non-fatal MI was less frequent with BAS (5.0% versus 9.2%, respectively; p = 0.025). Cardiac death and isc...
Journal Article•10.3109/14017431.2016.1143112•
Acute coronary angiography after coronary artery bypass grafting.

[...]

Karin Hultgren1, Anders Andreasson1, Tomas A Axelsson2, Per Albertsson1, Vincenzo Lepore1, Anders Jeppsson1 •
Sahlgrenska University Hospital1, University of Iceland2
18 Feb 2016-Scandinavian Cardiovascular Journal
TL;DR: Postoperative myocardial ischemia leading to acute coronary angiography is associated with increased short-term and long-term mortality and is a rare event after CABG.
Abstract: Objectives Coronary angiography is the golden standard when myocardial ischemia after CABG occurs. We summarize our experience of acute coronary angiography after CABG. Design All 4446 patients (mean age 68 ± 9 years, 22% women) who underwent CABG 2007 to 2012 were included in this retrospective observational study. Incidence, indications, findings, measures of acute angiography after CABG was assessed. Outcome variables were compared between patients who underwent angiography and those who did not. Results Eighty-seven patients (2%) underwent acute coronary angiography. Patients undergoing angiography had ECG changes (92%), echocardiographic alterations (48%), hemodynamic instability (28%), angina (15%), and/or arrhythmia (13%). Positive findings were detected in 69% of the cases. Only ECG changes as indication for angiography had a moderate association with positive findings, but the precision increased if other sign(s) of ischemia were present. Thirty-day mortality (7% versus 2%, p = 0.002) was...
Journal Article•10.3109/14017431.2015.1099721•
Flecainide attenuates rate adaptation of ventricular repolarization in guinea-pig heart.

[...]

Oleg E. Osadchii1•
University of Copenhagen1
01 Jan 2016-Scandinavian Cardiovascular Journal
TL;DR: Fleckcainide-induced arrhythmia may be partly accounted for by attenuated adaptation of ventricular repolarization to sudden changes in cardiac cycle length provoked by transient tachycardia or ectopic beats.
Abstract: Objectives: Flecainide is class Ic antiarrhythmic agent that was found to increase the risk of sudden cardiac death. Arrhythmic responses to flecainide could be precipitated by exercise, suggesting a role played by inappropriate rate adaptation of ventricular repolarization. This study therefore examined flecainide effect on adaptation of the QT interval and ventricular action potential duration (APD) to abrupt reductions of the cardiac cycle length. Design: ECG and ventricular epicardial and endocardial monophasic APD were recorded in isolated, perfused guinea-pig heart preparations upon a sustained cardiac acceleration (rapid pacing for 30 s), and following a single perturbation of the cycle length evoked by extrasystolic stimulation. Results: Sustained increase in heart rate was associated with progressive bi-exponential shortening of the QT interval and APD. Flecainide prolonged ventricular repolarization, delayed its rate adaptation, and decreased the amplitude of QT interval and APD shorteni...
Journal Article•10.1080/14017431.2016.1215519•
Warfarin treatment and risk of stroke among primary care patients with atrial fibrillation

[...]

Per Wändell1, Axel C. Carlsson1, Martin J. Holzmann2, Johan Ärnlöv3, Sven-Erik Johansson4, Jan Sundquist4, Kristina Sundquist4 •
Karolinska Institutet1, Karolinska University Hospital2, Uppsala University3, Lund University4
18 Aug 2016-Scandinavian Cardiovascular Journal
TL;DR: Warfarin is effective in preventing stroke in AF patients in primary healthcare, and is associated with a stroke preventing effect with fully adjusted HRs of 0.25 in women and 0.32 in men during a mean follow-up of 5.4 years.
Abstract: Objective. Our aim was to study the risk of a first ischaemic stroke (IS) in patients with atrial fibrillation (AF) treated in primary healthcare. Design. The study population included all adults (n = 11,517), 45 years and older diagnosed with AF, from 75 primary care centres in Sweden between 2001 and 2007. IS was defined as a hospital care event of stroke between 2001 and 2010. Association between incident stroke and warfarin treatment was explored using Cox regression analysis, with hazard ratios (HRs), and 95% confidence intervals (95%CIs). Adjustment was made for age, socioeconomic factors and co-morbidity. Results. Persistent treatment with warfarin was present among 33.7% of women and 40.0% among men. Persistent warfarin treatment, compared to no persistent treatment, was associated with a stroke preventing effect with fully adjusted HRs of 0.25 (95%CI 0.18–0.36) in women, and 0.25 (95%CI 0.19–0.32) in men. A CHA2DS2-VASc score of at least two among women, and three among men, was associate...
Journal Article•10.3109/14017431.2015.1091089•
CIED infection with either pocket or systemic infection presentation--complete device removal and long-term antibiotic treatment; long-term outcome.

[...]

Nikolaj Ihlemann, Michael Møller-Hansen, Kirsten Salado-Rasmussen, Regitze Videbæk, Claus Moser, Kasper Iversen1, Henning Bundgaard •
Herlev Hospital1
01 Jan 2016-Scandinavian Cardiovascular Journal
TL;DR: CIED infection with systemic or pocket infection was difficult to distinguish in clinical presentation and outcome, and complete device removal and antibiotic treatment of long duration was safe and without relapses.
Abstract: Objective: Cardiovascular implantable electronic device (CIED) infections are increasing in numbers. The objective was to review the clinical presentation and outcome in patients affected with CIED infections with either local pocket or systemic presentation. Design: All device removals due to CIED infection during the period from 2005 to 2012 were retrospectively reviewed. CIED infections were categorized as systemic or pocket infections. Treatment included complete removal of the device, followed by antibiotic treatment of six weeks. Results: Seventy-one device removals due to infection (32 systemic and 39 pocket infections) were recorded during the study period. Median follow-up time was 26 (IQR 9–41) months, 30 day and 12 month mortality were 4% and 14%, respectively. There was no long-term difference in mortality between patients with pocket vs. systemic infection (p = 0.48). During follow-up no relapses and two cases of new infections were noted (2.8%). Conclusions: CIED infection with syste...
Journal Article•10.1080/14017431.2016.1213876•
Intact endothelial and contractile function of coronary artery after 8 hours of heart preservation.

[...]

Guangqi Qin1, Trygve Sjöberg1, Qiuming Liao1, Xiaoke Sun1, Stig Steen1 •
Lund University1
03 Aug 2016-Scandinavian Cardiovascular Journal
TL;DR: Investigating if adequate preservation of coronary artery endothelium-dependent relaxation and contractility may be obtained after 8 hours of non-ischemic heart preservation found that it is possible after both intermittent and continuous perfusion.
Abstract: Objectives. The aim of the study was to investigate if adequate preservation of coronary artery endothelium-dependent relaxation and contractility may be obtained after 8 hours of non-ischemic heart preservation. Design. Porcine hearts were perfused for 8 hours at 8 °C, either in cycles of 15 minutes perfusion and 60 minutes non-perfusion, or by continuous perfusion. The perfusate consisted of a cardioplegic, hyperoncotic nutrition solution with oxygenated red cells, and the perfusion pressure was 20 mmHg. In organ baths, coronary artery segments from the preserved hearts were studied and compared to fresh controls. Results. Endothelium-dependent relaxation and contractility were fully preserved after both intermittent and continuous perfusion, as compared to fresh controls. No myocardial edema was seen; water content of the myocardium was 79.5 ± 0.2%, 79.0 ± 0.4% and 79.0 ± 0.3% (ns) for fresh controls, intermittently perfused, and continuously perfused hearts, respectively. Conclusion. Intact endothelial and contractile function of coronary artery may be obtained after 8 hours of non-ischemic heart preservation. (Less)
Journal Article•10.1080/14017431.2016.1235725•
Health-related quality-of-life after transapical transcatheter aortic valve implantation.

[...]

Christian E. Rex1, Johan Heiberg1, Kaj-Erik Klaaborg1, Vibeke E. Hjortdal1•
Aarhus University Hospital1
28 Sep 2016-Scandinavian Cardiovascular Journal
TL;DR: In low-risk patients with aortic valve stenosis undergoing TA-TAVI, no differences appeared in HRQoL compared with SAVR during a 5-year follow-up period, and there were no differences in survival during the 5 years.
Abstract: Purpose. Transcatheter aortic valve implantation (TA-TAVI) is a well-established treatment for aortic valve stenosis in high-risk patients and indications have been continuously expanding to also include intermediate-risk patients. However, in low-risk patients, experiences are still sparse and although clinical outcomes have been shown favorable results, HRQoL has remained unexplored. The aim of this report was to describe the long-term health-related quality-of-life (HRQoL) in low-risk patients randomized to TA-TAVI or surgical aortic valve replacement (SAVR). Methods. In a prospective, randomized trial, patients with aortic valve stenosis were randomized to either TA-TAVI or SAVR. TA-TAVI was performed through a mini thoracotomy with the introduction of prosthesis via the apex of the heart and antegradely advancement over the pre-dilated native valve. SAVR was performed during cardiopulmonary bypass with resection of the native valve and replacement with a prosthesis valve through a median ster...
Journal Article•10.3109/14017431.2016.1163415•
Safety and tolerability of regadenoson for myocardial perfusion imaging - first Danish experience.

[...]

Marianne Pape1, Helle D Zacho1, Jens Aarøe1, Svend Eggert Jensen1, Lars Jelstrup Petersen1 •
Aalborg University1
10 May 2016-Scandinavian Cardiovascular Journal
TL;DR: Evaluating safety and tolerability of the selective A2A receptor agonist, regadenoson, in patients referred for single photon emission computed tomography myocardial perfusion imaging (MPI) found it easy to use with a high frequency of AEs, which are generally mild in severity, transient, and resolve spontaneously.
Abstract: Objectives. Evaluating safety and tolerability of the selective A2A receptor agonist, regadenoson, in patients referred for single photon emission computed tomography myocardial perfusion imaging (MPI). Design. Observational study of patients referred for MPI stress testing using a 400 μg regadenoson (Rapiscan®) bolus. Hemodynamic variables and severity of adverse events (AE) were recorded before, during, and after administration. Results. A total of 232 patients were included. One or more AE were reported in 90% of patients; the AEs were graded mostly mild to moderate in severity, resolved spontaneously, and were mainly dyspnea, headache, and chest pain. No advanced heart block or bronchospasm were seen. Transient ST-segment changes developed in 10 patients. The maximum increase in heart rate was 19 ± 11 beats/minute. The mean systolic blood pressure decreased from 144 to 139 mmHg (p < 0.0001). Medical intervention was required in three patients: one case with severe hypotension and two cases wit...
Journal Article•10.3109/14017431.2015.1125012•
No association between glucose at age 30 and aortic diameter at age 65 in men: a population-based study.

[...]

Margaretha Persson, Moncef Zarrouk, Jan Holst, Peter M. Nilsson, Anders Gottsäter 
08 Jan 2016-Scandinavian Cardiovascular Journal
TL;DR: Fasting blood glucose in 33-year-old men was not associated with their aortic diameter at age 65 years, and potential pathophysiological processes linking disturbed glucose metabolism to a decreased risk for development of abdominal aorta aneurysm in men are probably not relevant until later in life.
Abstract: Objectives Impaired glucose metabolism and diabetes mellitus has been linked to a decreased risk for abdominal aortic aneurysm development in men. We evaluated potential relationships between blood glucose levels in 1722 men with mean age 34 years and their aortic diameter measured by ultrasound at age 65 years. Design Prospective cohort study. Results Mean follow-up between baseline glucose investigation and aortic ultrasound was 32.8 ± 1.8 years. There was no correlation between baseline blood glucose and later aortic diameter (r = 0.035, p = 0.146), whereas a weak correlation between body mass index (BMI) and aortic diameter was observed (r = 0.097 p < 0.001). In a partial correlation between aortic diameter and glucose levels adjusted for BMI, the correlation did not change (r = 0.011, p = 0.66). Neither were there any significant differences in mean aortic diameter between men belonging to different quartiles of baseline blood glucose levels (19.5, 19.1, 19.6 and 19.7 mm, p = 0.18). Conclusio...
Journal Article•10.3109/14017431.2015.1103892•
Stromal cell-derived factor 1α (SDF-1α): A marker of disease burden in patients with atrial fibrillation.

[...]

Dana Li1, Louise Bjørnager1, Anne Langkilde2, Ove Andersen2, Christian Jons1, Bue Ross Agner1, Ulrik Dixen1, Nadia Lander Landex3 •
University of Copenhagen1, Hvidovre Hospital2, Roskilde University3
01 Jan 2016-Scandinavian Cardiovascular Journal
TL;DR: In AF patients, a higher SDF-1α level was found in patients with a more progressive state of arrhythmia and was associated with longer hospitalizations.
Abstract: Objectives: Stromal cell-derived factor 1a (SDF-1α), is a chemokine and is able to home hematopoietic progenitor cells to injured areas of heart tissue for structural repair. Previous studies have found increased levels of SDF-1α in several cardiac diseases, but only few studies have investigated SDF-1α in patients with atrial fibrillation (AF). We aimed to test SDF-1α in a large cohort of patients with AF and its role as a prognostic marker. Design: Between January 1st 2008 to December 1st 2012, 290 patients with ECG documented AF were enrolled from the in- and outpatient clinics at the Department of Cardiology, Hvidovre Hospital, University of Copenhagen, Hvidovre, Denmark. Plasma levels of SDF-1α were measured using ELISA technique. Clinical data were registered and patient follow-up was conducted. Results: Patients with permanent AF had significantly higher SDF-1α levels (2199.5 pg/ml) than the patients with paroxysmal AF (1982.0 pg/ml) and persistent AF (1906.0 pg/ml), p < 0.0005. Higher SDF-...

Tools

SciSpace AgentBiomedical AgentSciSpace RecruitSciSpace for EnterpriseAgent GalleryChat with PDFLiterature ReviewAI WriterFind TopicsParaphraserCitation GeneratorExtract DataAI DetectorCitation Booster

Learn

ResourcesLive Workshops

SciSpace

CareersSupportBrowse PapersPricingSciSpace Affiliate ProgramCancellation & Refund PolicyTermsPrivacyData Sources

Directories

PapersTopicsJournalsAuthorsConferencesInstitutionsCitation StylesWriting templates

Extension & Apps

SciSpace Chrome ExtensionSciSpace Mobile App

Contact

support@scispace.com
SciSpace

© 2026 | PubGenius Inc. | Suite # 217 691 S Milpitas Blvd Milpitas CA 95035, USA

soc2
Secured by Delve